Post
of 102
Insider Financial article further says
Quote:NPHC intends to target this opportunity with Nyloxin, an OTC pain reliever for the treatment of moderate to severe chronic pain. It is formulated to treat back pain, neck pain, headaches, joint pain, migraines besides other types of pain.
We checked out the information about this product, and believe that the Nyloxin’s business strategy is smart. Nyloxin is intended for people without healthcare insurance, which is not a small number of individuals (42 million). Also, it is non-opiate and non-narcotic. Thus doctors should not be afraid of opiate side effects. The product targets those patients who cannot be treated with other products in the market.